Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04262310 · ClinicalTrials.gov registry record
Standardizing Method and Development of Normal Values to Measure Human Small Intestinal and Colonic Permeability
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT04262310: Completed study, sponsored by Mayo Clinic.
NCT04262310 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04262310 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
To develop a test to measure small bowel and colonic permeability.
Primary Outcome
Normal data on intestinal permeability in a Healthy human cohort: To summarize, using descriptive statistics, the median, 95% confidence interval, interquartile range of the following: * Urine excretion of probe molecules at 0-2h (reflecting small bowel permeability) with primary interest in 13C-mannitol and rhamnose * Urine excretion of probe molecules at 8-24h (reflecting colonic permeability) with primary interest in lactulose and sucralose * Urine excretion of probe molecules at 2-8h refle
Interventions
- OTHER Small Bowel and Colonic Permeability Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2021-02-26 |
What the finished NCT04262310 record still lists
NCT04262310 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Small Bowel and Colonic Permeability Test is the first listed.
NCT04262310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04262310 about?
NCT04262310 is a clinical study titled "Standardizing Method and Development of Normal Values to Measure Human Small Intestinal and Colonic Permeability". To develop a test to measure small bowel and colonic permeability.
What is the current status of trial NCT04262310?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2019-10-11. Estimated completion is 2021-02-26.
What interventions are being tested in trial NCT04262310?
The interventions under investigation include: Small Bowel and Colonic Permeability Test (OTHER).
Who is sponsoring clinical trial NCT04262310?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI